The Leukemia & Lymphoma Society (LLS) and Avila Therapeutics, Inc., today announced they have established a collaboration to support development of one of Avila's lead product candidates, AVL-292, for treatment of adults with B cell cancers....
Read More...
[Source: Society News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment